BRISTOL MYERS SQUIBB CO cotiza a 59.12 USD y tiene una capitalización bursátil de $120.8B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo …
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $2.04 | $1.58 | $1.26 |
| Estimado | $1.70 | $1.60 | $1.42 | $1.20 |
| Sorpresa | — | +27.5% | +11.3% | +5.0% |
| Métrica | BMY | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 71.1% | 57.0% | +14.0% |
| Operating Margin | — | -38.6% | — |
| Net Margin | 14.6% | -33.6% | +48.2% |
| FCF Margin | 26.6% | -13.9% | +40.5% |
| ROE | 38.2% | -40.4% | +78.6% |
| ROA | 7.8% | -32.0% | +39.8% |
| Current Ratio | 1.26 | 2.84 | -1.58 |
| Debt / Equity | 2.43 | 0.28 | +2.15 |